Efficacy of SOC cilta-cel in patients with prior BCMA-TT based on patient and treatment characteristics. (A) Response based on prior BCMA targeted therapy (yes/no). (B) Response based on time from prior BCMA-TT (<6 months vs ≥6 months). (C) PFS based on prior BCMA-directed therapy. (D) PFS based on types prior BCMA-directed therapy. (E) PFS based on the time from last BCMA therapy (<6 months vs ≥6 months).